Neovasc Inc. NVCN

Compassionate use, the patient was not enrolled in the trial

[Amor123]

Expanded access (sometimes called “compassionate use”) is the use of investigational drugs, biologics or medical devices outside the clinical trial setting for treatment purposes.  Expanded access may be appropriate when all the following apply:

• Patient has a serious disease or condition, or whose life is immediately threatened by their disease or condition.
• There is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition.
• Patient enrollment in a clinical trial is not possible.
• Potential patient benefit justifies the potential risks of treatment.
• Providing the investigational medical product will not interfere with investigational trials that could support a medical product’s development or marketing approval for the treatment indication 

[Amor123]

That means US patients can have the Reducer even before the FDA approval, that's really a major devolleppment